STOCK TITAN

Director David Plouffe granted 8,475 RSUs at Oscar Health (OSCR)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Plouffe David reported acquisition or exercise transactions in this Form 4 filing.

Oscar Health, Inc. reported that director David Plouffe received a grant of 8,475 restricted stock units (RSUs) tied to its Class A common stock. Following this equity award, his reported direct holdings total 137,121 shares.

The RSUs vest on the earlier of the one-year anniversary of the grant date or the next annual stockholders’ meeting, assuming continued service. Once vested, they are settled in Class A shares upon specified events such as separation from service, death, disability, or a change in control.

Positive

  • None.

Negative

  • None.
Insider Plouffe David
Role null
Type Security Shares Price Value
Grant/Award Class A Common Stock 8,475 $0.00 --
Holdings After Transaction: Class A Common Stock — 137,121 shares (Direct, null)
Footnotes (1)
  1. [object Object]
RSUs granted 8,475 RSUs Equity award to director David Plouffe
Holdings after transaction 137,121 shares Class A common stock directly owned after grant
Grant price per share $0.0000 per share Reported transaction price for RSU grant
restricted stock units ("RSUs") financial
"Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Class A common stock financial
"receive one share of Oscar Health, Inc. (the "Issuer") Class A common stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
change in control financial
"within five days following a change in control of the Issuer"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Plouffe David

(Last)(First)(Middle)
75 VARICK STREET, 5TH FLOOR

(Street)
NEW YORK NEW YORK 10013

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Oscar Health, Inc. [ OSCR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock06/04/2026A8,475(1)A$0137,121D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Consists of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Oscar Health, Inc. (the "Issuer") Class A common stock. The RSUs vest on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the next annual meeting of stockholders of the Issuer following the grant date, subject to continued service through the applicable vesting date. To the extent vested, the RSUs will be settled in shares of the Issuer's Class A common stock on the earliest of (i) the six-month anniversary of the director's separation from service, death or disability and (ii) within five days following a change in control of the Issuer.
Remarks:
/s/ Melissa Curtin, Attorney-in-fact06/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Oscar Health (OSCR) disclose for David Plouffe?

Oscar Health disclosed that director David Plouffe received a grant of 8,475 restricted stock units (RSUs). These RSUs represent potential future shares of Class A common stock, awarded as part of his director compensation rather than an open-market purchase.

How many Oscar Health (OSCR) shares does David Plouffe hold after this grant?

After the 8,475 RSU grant, David Plouffe is reported to hold 137,121 shares of Oscar Health Class A common stock. This figure reflects his direct ownership position following the award disclosed in the Form 4 filing.

When do David Plouffe’s RSUs from Oscar Health (OSCR) vest?

The RSUs vest on the earlier of the one-year anniversary of the grant date or the next annual meeting of stockholders. Vesting is conditioned on David Plouffe’s continued service as a director through the applicable vesting date.

What does each RSU granted to David Plouffe by Oscar Health (OSCR) represent?

Each RSU represents a contingent right to receive one share of Oscar Health Class A common stock. Delivery of the actual shares occurs after vesting and upon specified events such as separation from service, death, disability, or a change in control.

How and when will David Plouffe’s vested Oscar Health (OSCR) RSUs be settled?

Once vested, the RSUs are settled in Class A common shares on the earliest of the six-month anniversary of his separation from service, his death or disability, or within five days after a change in control of Oscar Health.